CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +7,500 | 75,215 | ||
| 2025-01-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −2,430 | $2.48 | $6K | 72,785 |
| 2025-01-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −7,500 | 15,000 | ||
| 2025-01-01 | Walker Neal INTERIM CEO | Option exercise | +9,467 | 1,443,097 | ||
| 2025-01-01 | Walker Neal INTERIM CEO | Shares withheld for taxes | −3,904 | $2.48 | $10K | 1,439,193 |
| 2025-01-01 | Walker Neal INTERIM CEO | Option exercise · Restricted Stock Units | −9,467 | 37,867 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Option exercise | +73,750 | 245,533 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −32,937 | 212,596 | ||
| 2024-12-31 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −73,750 | 73,750 | ||
| 2024-12-31 | Balthaser Kevin Chief Financial Officer | Option exercise | +73,750 | 98,447 | ||
| 2024-12-31 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −30,732 | $2.48 | $76K | 67,715 |
| 2024-12-31 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −73,750 | 73,750 | ||
| 2024-12-31 | Loerop James Chief Business Officer | Option exercise | +73,750 | 107,767 | ||
| 2024-12-31 | Loerop James Chief Business Officer | Shares withheld for taxes | −32,089 | $2.48 | $80K | 75,678 |
| 2024-12-31 | Loerop James Chief Business Officer | Option exercise · Restricted Stock Units | −73,750 | 73,750 | ||
| 2024-12-10 | Monahan Joseph Chief Scientific Officer | Gift | −15,000 | 171,783 | ||
| 2024-12-04 | Walker Neal INTERIM CEO | Option exercise | +118,840 | $1.52 | $181K | 1,501,973 |
| 2024-12-04 | Walker Neal INTERIM CEO | Shares withheld for taxes | −68,343 | $3.76 | $257K | 1,433,630 |
| 2024-12-04 | Walker Neal INTERIM CEO | Option exercise · Employee Stock Option (right to buy) | −118,840 | 0 | ||
| 2024-12-02 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +375,000 | 375,000 |
Page 10 of 34 · 680 trades